Page last updated: 2024-11-05

3-hydroxy-3-methylbutene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-hydroxy-3-methylbutene: narcotic, sleep-producing principle from hops; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3-hydroxy-3-methylbut-1-ene : A tertiary alcohol that is 3-methylbut-1-ene carrying a hydroxy substituent at position 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8257
CHEMBL ID4245903
CHEBI ID132752
MeSH IDM0088741

Synonyms (76)

Synonym
3-hydroxy-3-methyl-1-butene
methylbutenol
2-methyl-3-buten-2-yl alcohol
1,1-dimethyl-2-propanol
2-methyl-2-hydroxy-3-butene
ai3-23122
3-methyl-1-buten-3-ol
3-hydroxy-3-methylbutene
alpha,alpha-dimethylallyl alcohol
nsc 15977
3-butyn-2-ol, 2-methyl- (8ci,9ci)
1-buten-3-ol, 3-methyl-
einecs 204-068-4
2-methylbut-3-en-2-ol
3-methyl-buten-(1)-ol-(3) [german]
brn 1698263
inchi=1/c5h10o/c1-4-5(2,3)6/h4,6h,1h2,2-3h
.alpha.,.alpha.-dimethylallyl alcohol
3-buten-2-ol, 2-methyl-
nsc-15977
dimethylvinylmethanol
2-methyl-3-buten-2-ol
115-18-4
1,1-dimethylallyl alcohol
nsc15977
1,1-dimethyl-2-propenol
dimethylvinylcarbinol
1,1-dimethylallyl alchol
vinyldimethylcarbinol
2-methyl-3-butene-2-ol
2-methyl-3-buten-2-ol, >=98%
2-methyl-3-buten-2-ol, 98%
CHEBI:132752
3-hydroxy-3-methylbut-1-ene
ch2=chc(ch3)2oh
1,1-dimethyl-2-propen-1-ol
1,1-dimethyl-2-propenyl alcoho
2-methyl but-3-ene-2-ol
isoprenyl alcohol
M0178
AKOS009156785
4-01-00-02132 (beilstein handbook reference)
3-methyl-buten-(1)-ol-(3)
sh64he46l9 ,
ec 204-068-4
unii-sh64he46l9
FT-0612937
hydroxy-3-methylbutene, 3-
2-vinyl-2-propanol
3-methyl-but-1-en-3-ol
2-methyl-but-3-en-2-ol
dimethyl vinyl carbinol
3-methyl-3-hydroxybut-1-ene
3-methyl-buten-3-ol
2-methylbut-3-ene-2-ol
1,1-dimethyl-2-propenyl alcohol
3-methyl-1-butene-3-ol
dtxsid3047471 ,
NCGC00357265-01
tox21_303823
dtxcid1027471
cas-115-18-4
1-dimethyl-2-propenol
1-dimethylallyl alcohol
3-methylbut-1-en-3-ol
C21402
mfcd00004470
2-methyl-3-buten-2-ol, analytical standard
1, 1-dimethylallyl alcohol
1, 1-dimethyl-2-propenol
Q209432
AMY3791
STL570064
CHEMBL4245903
SB83756
EN300-84043

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dose-response of the beetle was first examined in a trapping experiment in August 1999."( Dose-dependent response and preliminary observations on attraction range of Ips typographus to pheromones at low release rates.
Franklin, AJ; Grégoir, JC, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
fragranceA substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell.
pheromoneA semiochemical used in olfactory communication between organisms of the same species eliciting a change in sexual or social behaviour.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
animal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in animals that include diverse creatures from sponges, insects to mammals.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
tertiary alcoholA tertiary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has three other carbon atoms attached to it.
olefinic compoundAny organic molecular entity that contains at least one C=C bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
methylbutenol biosynthesis14

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency0.13690.001530.607315,848.9004AID1224841
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1393287Antibacterial activity against Escherichia coli C3000 ATCC 15597 assessed as lowest concentration required for 7-log reduction in viable bacteria count after 1 hr2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.
AID1393289Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 assessed as lowest concentration required for 7-log reduction in viable bacteria count after 1 hr2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.
AID1393290Antibacterial activity against Enterococcus faecalis ATCC 19433 assessed as lowest concentration required for 7-log reduction in viable bacteria count after 1 hr2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.
AID1393288Antibacterial activity against Staphylococcus aureus assessed as lowest concentration required for 7-log reduction in viable bacteria count after 1 hr2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (11.76)18.7374
1990's2 (5.88)18.2507
2000's11 (32.35)29.6817
2010's17 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.53 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index5.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]